Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Roger B. Cohen, MD

Roger B. Cohen, MD Physician

Associate Director of Clinical Research, Abramson Cancer Center Director, Hematology/Oncology Fellowship Program Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is employed by Penn Medicine.

About Dr. Roger B. Cohen

Recognized by America's Top Doctors 2011 - 2018

Recognized by Best Doctors in America 2011 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues, 2011 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1993

Clinical Expertise:

  • Adenocarcinoma of Lung
  • Adenocarcinoma of the Head and Neck
  • Adenoid Cystic Carcinoma
  • ALK Translocation
  • Base of Skull Tumors
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Cancer of the Hard/Soft Palate
  • Cancer of the Nasal Cavity
  • Cancer of the Parotid
  • Cancer of the Supraglottis
  • Cancer of the Vocal Cords
  • Chemoradiation
  • Combined Modality Therapy
  • Diaphragm Tumor
  • Ear and Temporal Bone Tumors
  • EGFR Mutation
  • Esophageal Cancer
  • Face Cancer
  • Glottic Cancer
  • Head and Neck Tumor
  • Hypopharyngeal Cancer
  • Immunotherapy
  • Jaw Cancer
  • Kras Mutation
  • Large Cell Cancer of the Lung
  • Laryngeal Cancer
  • Lung Cancer Genomics
  • Lung Carcinoid Tumor
  • Malignant Neoplasm of Lip
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Mouth Cancer (Oral Cancer)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Pleural Cancer
  • Reirradiation for Recurrent Head and Neck Cancers
  • ROS1 Fusion
  • Salivary Gland Cancer
  • Sinus Cancer
  • Small Cell Lung Cancer
  • Squamous Cancer of the Lung
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma of the Jaw
  • Squamous Cell Carcinoma of the Mouth
  • Squamous Cell Carcinoma of the Throat
  • Squamous Cell Carcinoma of the Tonsils
  • Thoracic Cancer
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Thymus Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Tracheal Cancer
  • Tumor of Parotid Gland
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Harvard Medical School
Residency: Mount Sinai Medical Center
Fellowship: Mount Sinai Medical Center
Fellowship: National Cancer Institute


American Association for Cancer Research, National American Society of Clinical Oncology, National Eastern Cooperative Oncology Group, National Heat Biologics, National Millennium Pharmaceuticals Discovery Oncology Scientific Advisory Board, National

Hospital Affiliation

Dr. Cohen is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Brickman Cristina E, Propert Kathleen J, Merlin Jessica S, Liu Jeffrey C, Eady Sequoya, Mcghee-Jez Amy, Ragin Camille, Grover Surbhi, Cohen Roger B, Gross Robert: Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus. AIDS research and human retroviruses : 2019.

Chao Hann-Hsiang, Schonewolf Caitlin A, Tan Erik X, Swisher-McClure Samuel, Ghiam Alireza F, Weinstein Gregory S, O'Malley Bert W, Chalian Ara A, Rassekh Christopher H, Newman Jason G, Cohen Roger B, Bauml Joshua M, Aggarwal Charu, Lin Alexander, Lukens John N: The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation. Head & neck : 2019.

Bauml Joshua M, Mick Rosemarie, Ciunci Christine, Aggarwal Charu, Davis Christiana, Evans Tracey, Deshpande Charuhas, Miller Linda, Patel Pooja, Alley Evan, Knepley Christina, Mutale Faith, Cohen Roger B, Langer Corey J: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA oncology : 2019.

Gatto Nicolle M, Koralek Daniel O, Bracken Michael B, Duggan William T, Lem Joanna, Klioze Sol, Koch Gary G, Wise Robert A, Cohen Roger B, Jackson Neville C: Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-up Study of Patients Enrolled in Exubera-Controlled Clinical Trials (FUSE) Final Results. Diabetes care 42 (9): 1708-1715,2019.

Bagley Stephen J, Talento Suzanna, Mitra Nandita, Meropol Neal J, Cohen Roger B, Langer Corey J, Vachani Anil: Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network : JNCCN 17 (5): 469-477,2019.

Liou Kevin T, Hung Tony K W, Meghani Salimah H, Epstein Andrew S, Li Q Susan, Romero Sally A D, Cohen Roger B, Mao Jun J: What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals. Pain medicine (Malden, Mass.) : 2019.

He Aiwu Ruth, Cohen Roger B, Denlinger Crystal S, Sama Ashwin, Birnbaum Ariel, Hwang Jimmy, Sato Takami, Lewis Nancy, Mynderse Michelle, Niland Michele, Giles Jennifer, Wallin Johan, Moser Brian, Zhang Wei, Walgren Richard, Plimack Elizabeth R: First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. The oncologist : 2019.

Bauml Joshua M, Vinnakota Ravi, Anna Park Yeun-Hee, Bates Susan E, Fojo Tito, Aggarwal Charu, Di Stefano Jessica, Knepley Christina, Limaye Sewanti, Mamtani Ronac, Wisnivesky Juan, Damjanov Nevena, Langer Corey J, Cohen Roger B, Sigel Keith: Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data. Cancer 125 (3): 406-415,2019.

Bange Erin, Marmarelis Melina E, Hwang Wei-Ting, Yang Yu-Xiao, Thompson Jeffrey C, Rosenbaum Jason, Bauml Joshua M, Ciunci Christine, Alley Evan W, Cohen Roger B, Langer Corey J, Carpenter Erica, Aggarwal Charu: Impact of and Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With -Mutated Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 3 : 2019.

Swed Brandon L, Cohen Roger B, Aggarwal Charu: Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience. JCO precision oncology 3 : 2019.

Academic Contact Info

Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-139

Philadelphia, PA 19104
Phone: (215) 662-4469
Patient appointments: 800-789-7366 (PENN)